These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 32599245)
21. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans. Srivastava R; Daulatabad SV; Srivastava M; Janga SC Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993015 [TBL] [Abstract][Full Text] [Related]
22. Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2'-O-Methylation of Viral RNA. Encinar JA; Menendez JA Viruses; 2020 May; 12(5):. PubMed ID: 32397643 [TBL] [Abstract][Full Text] [Related]
23. Interferon-Induced Transmembrane Protein (IFITM3) Is Upregulated Explicitly in SARS-CoV-2 Infected Lung Epithelial Cells. Hachim MY; Al Heialy S; Hachim IY; Halwani R; Senok AC; Maghazachi AA; Hamid Q Front Immunol; 2020; 11():1372. PubMed ID: 32595654 [TBL] [Abstract][Full Text] [Related]
24. Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19. Barh D; Tiwari S; Weener ME; Azevedo V; Góes-Neto A; Gromiha MM; Ghosh P Comput Biol Med; 2020 Nov; 126():104051. PubMed ID: 33131530 [TBL] [Abstract][Full Text] [Related]
25. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients. Zhou Z; Ren L; Zhang L; Zhong J; Xiao Y; Jia Z; Guo L; Yang J; Wang C; Jiang S; Yang D; Zhang G; Li H; Chen F; Xu Y; Chen M; Gao Z; Yang J; Dong J; Liu B; Zhang X; Wang W; He K; Jin Q; Li M; Wang J Cell Host Microbe; 2020 Jun; 27(6):883-890.e2. PubMed ID: 32407669 [TBL] [Abstract][Full Text] [Related]
26. Network perturbation analysis in human bronchial epithelial cells following SARS-CoV2 infection. Nunnari G; Sanfilippo C; Castrogiovanni P; Imbesi R; Li Volti G; Barbagallo I; Musumeci G; Di Rosa M Exp Cell Res; 2020 Oct; 395(2):112204. PubMed ID: 32735892 [TBL] [Abstract][Full Text] [Related]
27. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Appelberg S; Gupta S; Svensson Akusjärvi S; Ambikan AT; Mikaeloff F; Saccon E; Végvári Á; Benfeitas R; Sperk M; Ståhlberg M; Krishnan S; Singh K; Penninger JM; Mirazimi A; Neogi U Emerg Microbes Infect; 2020 Dec; 9(1):1748-1760. PubMed ID: 32691695 [TBL] [Abstract][Full Text] [Related]
28. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Arunachalam PS; Wimmers F; Mok CKP; Perera RAPM; Scott M; Hagan T; Sigal N; Feng Y; Bristow L; Tak-Yin Tsang O; Wagh D; Coller J; Pellegrini KL; Kazmin D; Alaaeddine G; Leung WS; Chan JMC; Chik TSH; Choi CYC; Huerta C; Paine McCullough M; Lv H; Anderson E; Edupuganti S; Upadhyay AA; Bosinger SE; Maecker HT; Khatri P; Rouphael N; Peiris M; Pulendran B Science; 2020 Sep; 369(6508):1210-1220. PubMed ID: 32788292 [TBL] [Abstract][Full Text] [Related]
30. Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19. Carter-Timofte ME; Jørgensen SE; Freytag MR; Thomsen MM; Brinck Andersen NS; Al-Mousawi A; Hait AS; Mogensen TH Front Immunol; 2020; 11():1606. PubMed ID: 32695122 [TBL] [Abstract][Full Text] [Related]
31. A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi. Vavougios GD Med Hypotheses; 2020 Jul; 140():109759. PubMed ID: 32344305 [TBL] [Abstract][Full Text] [Related]
32. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse. Gardinassi LG; Souza COS; Sales-Campos H; Fonseca SG Front Immunol; 2020; 11():1636. PubMed ID: 32670298 [TBL] [Abstract][Full Text] [Related]
34. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Blanco-Melo D; Nilsson-Payant BE; Liu WC; Uhl S; Hoagland D; Møller R; Jordan TX; Oishi K; Panis M; Sachs D; Wang TT; Schwartz RE; Lim JK; Albrecht RA; tenOever BR Cell; 2020 May; 181(5):1036-1045.e9. PubMed ID: 32416070 [TBL] [Abstract][Full Text] [Related]
35. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology. Chen X; Yin YH; Zhang MY; Liu JY; Li R; Qu YQ Int J Med Sci; 2020; 17(16):2511-2530. PubMed ID: 33029094 [TBL] [Abstract][Full Text] [Related]
36. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection. Mousavi SZ; Rahmanian M; Sami A Infect Genet Evol; 2020 Dec; 86():104610. PubMed ID: 33130005 [TBL] [Abstract][Full Text] [Related]
37. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Xiong Y; Liu Y; Cao L; Wang D; Guo M; Jiang A; Guo D; Hu W; Yang J; Tang Z; Wu H; Lin Y; Zhang M; Zhang Q; Shi M; Liu Y; Zhou Y; Lan K; Chen Y Emerg Microbes Infect; 2020 Dec; 9(1):761-770. PubMed ID: 32228226 [TBL] [Abstract][Full Text] [Related]
38. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing. Das AB BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131 [TBL] [Abstract][Full Text] [Related]